Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2025-12-24 @ 1:14 PM
NCT ID:
NCT03239795
Eligibility Criteria:
Inclusion Criteria:
* All patients aged 65 years and more
* Pregnant women
* Patients with a chronic long lasting disease needing yearly seasonal influenza immunization
* respiratory diseases: COPD, emphysema, asthma, silicosis, Bronchial dilatation, cystic fibrosis, other respiratory diseases at risk of influenza complications
* cardiovascular diseases: Congenital heart disease, heart failure, valvulopathy, rhythm disorder, coronary heart disease, stroke, infarction, coronary bypass
* neurologic diseases: Myopathy, multiple sclerosis, sequelae of stroke, dementia (Alzheimer or others), poliomyelitis, gravis, paraplegia or tetraplegia reaching the diaphragm
* kidney and liver diseases: severe kidney failure, nephrotic syndrome, chronic hepatitis, cirrhosis
* metabolic disorders: diabetes, malignant obesity
* immunity disorders and blood diseases: cancer and other malignant diseases, organ and marrow transplantation, immune deficiency, Inflammatory and autoimmune diseases with immunosuppressive medication, HIV infection, sickle cell disease.
Exclusion Criteria:
* patients aged less than 16 years
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT03239795
Study Brief:
Protocol Section:
NCT03239795